Improve Autism and IDD Care with AI-Powered Assessments: CentralReach and AI.Measures Partnership

What You Should Know:

–  CentralReach, the leader in autism and intellectual and developmental disabilities (IDD) care software announces the establishment of its exclusive strategic partnership with Dr. Thomas Frazier’s next generation assessment company, AI.Measures, the leader in evidence-based, norm-referenced assessments for child mental health, including behavioral intervention for autism.

-This collaboration will enable therapy providers to access AI.Measures’ innovative solutions, providing them  the opportunity to begin to standardize the assessment process and receive treatment recommendations based on each patient’s characteristics. 

Revolutionizing Autism and IDD Care with Comprehensive, AI-Driven Solutions

CentralReach is the leading provider of autism and intellectual and developmental disabilities (IDD) care software, offering the only complete, end-to-end platform designed to enhance care at home, school, and work. Rooted in Applied Behavior Analysis (ABA), CentralReach empowers professionals with powerful and intuitive solutions that help individuals with autism spectrum disorder (ASD) and related IDD unlock their potential, achieve better outcomes, and lead more independent lives. Trusted by over 185,000 professionals worldwide, the company is committed to continuous product advancement, industry-leading expertise, and world-class client support, driving autism and IDD care into a new era of excellence.

CentralReach’s latest integration introduces a groundbreaking feature that enables providers to leverage proprietary, evidence-based algorithms to deliver tailored care—an innovation unmatched by any other autism assessment tool. Initially available as a standalone solution through CentralReach, this feature will ultimately be incorporated into the Care360 platform, enhancing value-based care reporting and standardization. By placing therapy providers in control of determining the appropriate treatment dosage for each patient, this integration streamlines clinical decision-making and improves patient outcomes.

As part of its comprehensive approach, CentralReach has acquired the ABLLS-R® and AFLS® assessments, along with SILAS™, an assessment-driven platform for social-emotional learning, executive function, and vocational training. These acquisitions reinforce the company’s vision of a holistic and data-driven assessment framework that informs both individualized care plans and outcome expectations.

The integration of AI.Measures’ assessment tools within the CR Assessment platform further enhances clinical capabilities by enabling professionals to:

·       Standardize the assessment process with norm-referenced evaluations that generate evidence-based treatment recommendations.

·       Optimize intervention strategies by tailoring treatment plans based on data-driven insights.

·       Enhance care coordination through seamless integration within the Care360 platform, ensuring continuity of care across all settings.

·       Advance the assessment process by incorporating video-based data collection and analysis to improve accuracy and efficiency.

With these advancements, CentralReach continues to set new standards in autism and IDD care, equipping providers with the tools needed to deliver comprehensive, high-quality, and personalized care at scale.